Development of PARP and Immune-Checkpoint Inhibitor Combinations

Cancer Research - United States
doi 10.1158/0008-5472.can-18-2652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy